JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹839 Cr | ₹77 Cr | ₹-61 Cr | ₹414 Cr | ₹836 Cr |
What is the latest Consolidated Net Profit of JUBILANT PHARMOVA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹839 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹-61 Cr |
| Mar2022 | ₹414 Cr |
| Mar2021 | ₹836 Cr |
How is Consolidated Net Profit of JUBILANT PHARMOVA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹839 Cr | 988.72 | |
| Mar2024 | ₹77 Cr | Positive | |
| Mar2023 | ₹-61 Cr | Negative | |
| Mar2022 | ₹414 Cr | -50.48 | |
| Mar2021 | ₹836 Cr | - | |
Compare Consolidated Net Profit of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹13,230.7 Cr | -3.4% | -14.2% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -3.4% |
-14.2% |
-9.3% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses